Interactions of amiloride with alpha- and beta-adrenergic receptors: amiloride reveals an allosteric site on alpha 2-adrenergic receptors

MJ Howard, RJ Hughes, HJ Motulsky, MD Mullen and PA Insel

Interaction of amiloride with adrenergic receptors was studied using radioligand binding techniques. Amiloride competed for [3H]prazosin binding to alpha 1-adrenergic receptors on rat renal cortical membranes and BC3H-1 muscle cell membranes. Non-linear regression analysis of radioligand binding isotherms showed that amiloride increased Kd without a change in Bmax, suggesting the drug binds competitively in a mutually exclusive manner with the radioligand at the receptor-binding site. Similarly, amiloride competitively blocked [125I]iodocyanopindolol binding to beta-adrenergic receptors on both tissues. The addition of guanylyl 5'-imidodiphosphate or sodium chloride did not alter the interaction of amiloride with alpha 1- or beta-adrenergic receptors. The interaction of amiloride with alpha 2- adrenergic receptors was more complex and revealed an allosteric site. In both rat renal cortical membranes and intact human platelets, amiloride increased the Kd for [3H]rauwolscine binding, as well as decreasing the apparent Bmax. In binding experiments where amiloride competed for [3H]rauwolscine-binding sites, pseudo-Hill slopes of less than 1.0 were obtained for both platelet and renal alpha 2 receptors. In addition, amiloride increased the rate of [3H]rauwolscine dissociation from renal alpha 2 receptors. In the presence of 100-120 mM sodium chloride, the Ki for amiloride competition was decreased an average of 54% in renal membranes; in contrast, sodium increased the Kd of the agonist epinephrine. Taken together, these data support the hypothesis that alpha 2-adrenergic receptors, but not alpha 1- or beta- adrenergic receptors, have an allosteric site to which amiloride binds and which we propose to be a cation-binding site.

Volume 32, Issue 1, pp. 53-58, 07/01/1987
Copyright © 1987 by American Society for Pharmacology and Experimental Therapeutics

This article has been cited by other articles:

				R. A. Leppik, A. Mynett, S. Lazareno, and N. J. M. Birdsall Allosteric Interactions between the Antagonist Prazosin and Amiloride Analogs at the Human alpha 1A-Adrenergic Receptor Mol. Pharmacol., March 1, 2000; 57(3): 436 - 445. [Abstract] [Full Text]

				R. A. Leppik, S. Lazareno, A. Mynett, and N. J. M. Birdsall Characterization of the Allosteric Interactions between Antagonists and Amiloride Analogues at the Human alpha 2A-Adrenergic Receptor Mol. Pharmacol., May 1, 1998; 53(5): 916 - 925. [Abstract] [Full Text]

				E. A. Thomas, M. J. Carson, M. J. Neal, and J. G. Sutcliffe Unique allosteric regulation of 5-hydroxytryptamine receptor-mediated signal transduction by oleamide PNAS, December 9, 1997; 94(25): 14115 - 14119. [Abstract] [Full Text] [PDF]